Forest Laboratories has just released their latest FDA-approved medication to treat adults with Major Depressive Disorder called “Fetzima” with the generic name of “Levomilnacipran ER”. It is available in 20mg, 40mg, 80mg and 120mg tablets. It works on Serotonin and Norepinephrine receptors, which means that it is a cousin of antidepressants such as Cymbalta, Effexor, and […]
Introducing the New Kid on the Block to Treat Depression: “Brintellix”. October 1, 2013-Takeda Pharmaceuticals has just released their latest FDA-approved medication to treat adults with Major Depressive Disorder called “Brintellix” with the generic name of “Vorioxetine”. It is available in 5mg, 10mg, and 20mg tablets. It works on Serotonin receptors, which means that it […]
Highlight: Abilify Maintena Have I taken my meds today? I think so. This morning, right? No, that was yesterday… The lastest breakthrough in new psychiatry meds is Abilify Maintena. Currently, it is only FDA-approved for the treatment of Schizophrenia. But remember all those TV ads about Abilify being used to make your antidepressant work better? […]
The FDA recently called for a decrease in the recommended dosage of Ambien, a medication used to treat people who have trouble going to sleep. This was in part due to many reports of people having a sleep-walking type of event in which the person feels wide awake at the time, but has no memory […]
Pfizer Pipeline: New Drugs In The Making (August 9, 2013) – Pfizer is in the process of developing the following new drugs that may prove very useful in the field of Psychiatry drugs: AAC-001 (Phase 2): New Alzheimer’s disease vaccine AAB-003 (Phase 1): New biologic Alzheimer’s treatment SAM-760 (Phase 3): New Alzheimer’s treatment PF-04958242 (Phase […]